Amoy Diagnostics Co (SZSE:300685) Other Net Income (Loss) : ¥-0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Other Net Income (Loss)?

Amoy Diagnostics Co's Other Net Income (Loss) for the three months ended in Jun. 2024 was ¥-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥-0 Mil.

Amoy Diagnostics Co's quarterly Other Net Income (Loss) stayed the same from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥0 Mil) but then declined from Mar. 2024 (¥0 Mil) to Jun. 2024 (¥-0 Mil).

Amoy Diagnostics Co's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥-0 Mil) but then stayed the same from Dec. 2022 (¥-0 Mil) to Dec. 2023 (¥-0 Mil).

Amoy Diagnostics Co Other Net Income (Loss) Historical Data

The historical data trend for Amoy Diagnostics Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Other Net Income (Loss) Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Amoy Diagnostics Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Amoy Diagnostics Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Amoy Diagnostics Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Amoy Diagnostics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co Headlines

No Headlines